PKM2 inhibitor suppresses kidney fibrogenesis by disrupting YAP-TEAD-CCN2 transcriptional signaling following ischemia-reperfusion injury.

J Biol Chem · 2026 · PMC12803839 · PMID 41380965

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an increasing trendno p-value reported

Although PKM2 expression exhibited an increasing trend up to 24 h, compound 3k treatment did not significantly alter PKM2 expression levels at any time point.

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.